AssetMark’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
AssetMark's IRMD Position: Q3 2026 in Review
AssetMark held its iRadimed (IRMD) position steady in Q3 2026 at 47 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.
AssetMark first reported a position in IRMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.52K in Q1 2026. 157 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- AssetMark held 47 shares of iRadimed worth $4.05K as of Q3 2026.
- AssetMark left its iRadimed share count unchanged in Q3 2026.
- iRadimed made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2824 holding.
- AssetMark first reported a position in iRadimed in Q1 2025 and has held it in 7 quarters since.
- AssetMark's iRadimed position peaked at $4.52K in Q1 2026.
- 157 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.